CARL L GORDON Transaction History

Date Transaction Value Shares Traded Form
Aug 13 2024
SELL
Open market or private sale
$11,002,500 $44.01 p/Share
250,000

Also insider at

TPTX
Turning Point Therapeutics, Inc.
KNTE
Kinnate Biopharma Inc. Healthcare
PRVL
Prevail Therapeutics Inc.
TERN
Terns Pharmaceuticals, Inc. Healthcare
ACET
Adicet Bio, Inc. Healthcare
ORIC
Oric Pharmaceuticals, Inc. Healthcare
GMTX
Gemini Therapeutics, Inc. Healthcare
THRX
Theseus Pharmaceuticals, Inc. Healthcare
CMPX
Compass Therapeutics, Inc. Healthcare
AVBP
ArriVent Biopharma, Inc.
MBX
MBX Biosciences, Inc.
CLG

Carl L Gordon

Director
San Diego, CA

Track Institutional and Insider Activities on KROS

Follow Keros Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KROS shares.

Notify only if

Insider Trading

Get notified when an Keros Therapeutics, Inc. insider buys or sells KROS shares.

Notify only if

News

Receive news related to Keros Therapeutics, Inc.

Track Activities on KROS